Aqilion AB

P.U.L.S. AB is a principal investment firm specializing in investments in early stage projects and incubation. It seeks to invest in life sciences, pharmaceuticals, diagnostics, and medical technology. Within life sciences it primarily focuses on drug development and medicinal products and a secondary focus on medical devices. It targets investments in Sweden and the Nordic region. The firm seeks to invest between SEK 15 million ($2.52 million) and SEK 30 million ($4.40 million) per project. The firm seeks to hold its investments for a period of three to five years. It seeks to exit its investments through trade sale. The firm seeks to take a Board seat in its investee companies. P.U.L.S. AB was founded in 2002 and is based in Helsingborg, Sweden with additional offices in Göteborg, Sweden and Danderyd, Sweden.